The Indications for Hepatectomy for Multinodular Hepatocellular Carcinoma: Experience from a Single Institution

被引:1
|
作者
Zhou, Yuan-da [1 ]
Li, Hui-kai [1 ]
Cui, Yun-long [1 ]
Zhang, Ti [1 ]
Li, Qiang [1 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Hepatobiliary Canc, Key Lab Canc Prevent & Therapy, Tianjin 300000, Peoples R China
关键词
Hepatectomy; Prognosis; Hepatocellular carcinoma; Multinodular; PERCUTANEOUS RADIOFREQUENCY ABLATION; PREOPERATIVE PLATELET COUNT; LIVER RESECTION; MULTIINSTITUTIONAL ANALYSIS; SURGICAL RESECTION; SELECTING PATIENTS; MILAN CRITERIA; TRANSPLANTATION; MANAGEMENT; SURVIVAL;
D O I
10.1159/000370128
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims: This study was conducted in order to investigate the indications for hepatecomy for multinodular hepatocellular carcinoma (MNHCC) in single institution. Methods: We retrospectively analyzed the medical records from 55 MNHCC patients, mainly with Child-Pugh A liver function, who underwent hepatectomy from January 2006 to December 2008. Both short-and long-term outcomes were analyzed. In addition, the prognostic significance of clinicopathological factors on overall survival (OS) was investigated by univariate analysis using the log-rank test. A Cox proportional hazards model was used in a subsequent multivariate analysis. Results: The perioperative morbidity rate (grade II or higher) was 18.2% (n = 10), and the in-hospital mortality rate was 3.6%. The median OS was 23.9 months (range, 2.5-84 months), whereas the median disease-free survival was 8.75 months (range, 1-65 months). Independent prognostic risk factors of 5-year OS included the number of tumors >2 (p = 0.032) and gross morphology indicating multiple tumor nodules scattered throughout the liver (p = 0.009). Conclusions: The postoperative morbidity and mortality rates were acceptable. The number of tumors >2 and gross morphology indicating multiple tumor nodules scattered throughout the liver were independent prognostic risk factors for patients with MNHCC after hepatectomy. Patients with both of these features had a very poor prognosis and were not considered suitable for surgery. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [1] Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
    Wang, Being-Whey
    Mok, King-Tong
    Liu, Shiuh-Inn
    Chou, Nan-Hwa
    Tsai, Cheng-Chung
    Chen, I-Shu
    Yeh, Ming-Hsin
    Chen, Yu-Chia
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (08) : 616 - 626
  • [2] Prognosis and recurrence of spontaneously ruptured hepatocellular carcinoma treated after hepatectomy: A single institution experience
    Xu, KangHe
    Ryu, DongHee
    Choi, Hanlim
    Choi, Jae-Woon
    Lee, Jiho
    MEDICINE, 2024, 103 (24) : e38555
  • [3] Cirrhotomimetic Hepatocellular Carcinoma: A Single Institution Experience
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1559 - 1561
  • [4] Cirrhotomimetic Hepatocellular Carcinoma: A Single Institution Experience
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1559 - 1561
  • [5] Hepatectomy for Huge Hepatocellular Carcinoma: Single Institute’s Experience
    Lianyue Yang
    Jiangfeng Xu
    Dipeng Ou
    Wei Wu
    Zhijun Zeng
    World Journal of Surgery, 2013, 37 : 2189 - 2196
  • [6] Hepatectomy for Huge Hepatocellular Carcinoma: Single Institute's Experience
    Yang, Lianyue
    Xu, Jiangfeng
    Ou, Dipeng
    Wu, Wei
    Zeng, Zhijun
    WORLD JOURNAL OF SURGERY, 2013, 37 (09) : 2189 - 2196
  • [7] Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy?
    Donadon, Matteo
    Fontana, Andrea
    Procopio, Fabio
    Del Fabbro, Daniele
    Cimino, Matteo
    Vigano, Luca
    Palmisano, Angela
    Torzilli, Guido
    UPDATES IN SURGERY, 2019, 71 (01) : 57 - 66
  • [8] Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy?
    Matteo Donadon
    Andrea Fontana
    Fabio Procopio
    Daniele Del Fabbro
    Matteo Cimino
    Luca Viganò
    Angela Palmisano
    Guido Torzilli
    Updates in Surgery, 2019, 71 : 57 - 66
  • [9] Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    HEPATIC ONCOLOGY, 2021, 8 (01)
  • [10] Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience
    Falkson, Samuel R.
    Bhambhvani, Hriday P.
    Gephart, Melanie Hayden
    WORLD NEUROSURGERY, 2020, 140 : E27 - E32